Pharmaceutical company Eli Lilly is looking to roll out a daily weight loss pill for patients with obesity and type 2 ...

Eli Lilly's next generation of weight loss drugs appear to show promise, possibly leading to even faster weight loss and added health benefits, early trial results suggest. The pharmaceutical company ...

Although there is one GLP-1 medication, Rybelsus, currently given as a daily pill, it has so far only been prescribed as a ...

Investing.com -- Eli Lilly stock dropped 5% on Wednesday after rival Novo Nordisk announced disappointing results from its ...

Eli Lilly posts 54% revenue growth with Zepbound, Mounjaro, expanding pipeline, and rising market share. Learn why LLY stock ...

Bridgewater Associates, LP, managed by Ray Dalio, recently executed a significant transaction involving Eli Lilly And Company ( (LLY) ). The hedge fund increased its position by 10,441 shares.

UnitedHealth Group is working with Eli Lilly on a clinical trial that will study at-home infusions of the drugmaker’s COVID-19 antibody treatment. Eli Lilly’s antibody drug, bamlanivimab, has received ...

Drugmaker Eli Lilly said Tuesday it is pausing its trial of a combination antibody treatment for coronavirus for safety reasons. Usually, clinical trials are paused because a volunteer has suffered a ...

Eli Lilly’s remarkable outperformance within the pharmaceutical sector hasn’t tempered enthusiasm, analysts are still ...